BCL2L1 and B-cell chronic lymphocytic leukemia: A combination of other SPLMs spliceostatin A (SSA) with either ABT-263 or ABT-199 (both are Bcl-2/Bcl-xL antagonists) led to apoptosis in CLL-B cells [17].